Emcure to acquire remaining stake in Zuventus Healthcare
The transaction is expected to close in Q2 FY 2026
The transaction is expected to close in Q2 FY 2026
The company received seven observations in the Form-483
The GMP-compliant facility with automated environmental monitoring accommodates both white room and class 7 and 8 cleanroom space
The company received one observation in the Form-483
The inspection concluded successfully, with the facility found to be in compliance with the required regulations
The decision to advance subcutaneous and oral amycretin into phase 3 is based on feedback received from regulatory authorities
The collaboration furthers AstraZeneca’s presence in China following the $2.5bn investment in Beijing
The project will be instrumental in enhancing the company's API manufacturing capacity and global reach
The company received 1 (One) observation in the Form-483
Subscribe To Our Newsletter & Stay Updated